Insulin Aspart recalls
The FDA has published 5 recalls involving Insulin Aspart since 2021. The latest was reported on 21 Apr 2021. Most were for temperature abuse. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls5since 2021
Last 12 months0reported
Class I5100% of total
Ongoing0latest 21 Apr 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 5 100%Class II 0 0%Class III 0 0%
Why insulin aspart is recalled
Companies
Brands
By year
All insulin aspart recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | NovoLog (Insulin aspart) Injection/mL (U-100) recalled by Novo NordiskNovolog | Novo Nordisk | Temperature Abuse | Nationwide |
| Drug | CLASS I | Fiasp FlexTouch (insulin aspart injection)/mL recalled by Novo NordiskFiasp | Novo Nordisk | Temperature Abuse | Nationwide |
| Drug | CLASS I | Fiasp (insulin aspart injection)/mL (U-100) recalled by Novo NordiskFiasp | Novo Nordisk | Temperature Abuse | Nationwide |
| Drug | CLASS I | Fiasp PenFill (insulin aspart injection)/mL recalled by Novo NordiskFiasp | Novo Nordisk | Temperature Abuse | Nationwide |
| Drug | CLASS I | NovoLog FlexPen (insulin aspart) Injection/mL Prefilled recalledNovolog | Novo Nordisk | Temperature Abuse | Nationwide |
Should you stop taking Insulin Aspart?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.